Z. Zajkowska

发表

CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice

Caleb Webber, Guy B. Williams, Mara Cercignani, 2019, Brain : a journal of neurology.

Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?

C. Pariante, P. Zunszain, Z. Zajkowska, 2015, Psychopharmacology.

Remote measurement technologies for depression in young people: A realist review with meaningful lived experience involvement and recommendations for future research and practice

V. Mondelli, M. Malys, A. van Heerden, 2022, medRxiv.

Inflammatory biomarkers in Alzheimer's disease plasma

Magda Tsolaki, Edward T. Bullmore, Gareth J. Barker, 2019, Alzheimer's & Dementia.

P.0688 Investigating the biological mechanisms underlying the risk of developing adolescent depression in Brazil: the IDEA Project

C. Kieling, J. Swartz, A. Cattaneo, 2021, European Neuropsychopharmacology.

First-Episode Psychosis: An Inflammatory State?

V. Mondelli, Z. Zajkowska, 2014, Neuroimmunomodulation.

Exploring the role of immune pathways in the risk and development of depression in adolescence: Research protocol of the IDEA-FLAME study

C. Kieling, M. Marizzoni, P. Di Meglio, 2021, Brain, behavior, & immunity - health.

P292. Sex Differences in a Double-Blind Randomized Clinical Trial With Minocycline in Treatment-Resistant Depressed Patients: CRP and IL-6 as Sex-Specific Predictors of Treatment Response

C. Pariante, A. Cleare, N. Mariani, 2022, Biological Psychiatry.

S0033291721000088jra 3289..3296

E. Bullmore, P. Cowen, C. Pariante, 2022 .

Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial

A. Young, C. Pariante, A. Cleare, 2021, Neuropsychopharmacology.

Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome

M. Hotopf, C. Pariante, N. Harrison, 2019, Psychoneuroendocrinology.

Sex differences in a double-blind randomized clinical trial with minocycline in treatment-resistant depressed patients: CRP and IL-6 as sex-specific predictors of treatment response

C. Pariante, N. Mariani, V. Mondelli, 2022, Brain, Behavior, and Immunity.

The influence of comorbid depression and overweight status on peripheral inflammation and cortisol levels

E. Bullmore, P. Cowen, C. Pariante, 2021, Psychological Medicine.

The role of circulatory systemic environment in predicting interferon-alpha–induced depression: The neurogenic process as a potential mechanism

C. Pariante, S. Thuret, V. Mondelli, 2019, Brain, Behavior, and Immunity.

Differential effect of interferon-alpha treatment on AEA and 2-AG levels

M. Hotopf, C. Pariante, V. Mondelli, 2020, Brain, Behavior, and Immunity.

Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study

E. Bullmore, P. Cowen, W. Drevets, 2020, Translational Psychiatry.

Psychological and contextual risk factors for first‐onset depression among adolescents and young people around the globe: A systematic review and meta‐analysis

C. Kieling, V. Mondelli, H. Fisher, 2022, Early intervention in psychiatry.

Towards a personalized treatment in depression: endocannabinoids, inflammation and stress response.

P. Zunszain, Z. Zajkowska, A. Englund, 2014, Pharmacogenomics.

Childhood trauma, HPA axis activity and antidepressant response in patients with depression

E. Bullmore, P. Cowen, C. Pariante, 2019, Brain, Behavior, and Immunity.

Frontolimbic network topology associated with risk and presence of depression in adolescents: A study using a composite risk score in Brazil.

C. Kieling, L. Rohde, J. Swartz, 2022, Biological psychiatry. Cognitive neuroscience and neuroimaging.

Cortisol and development of depression in adolescence and young adulthood – a systematic review and meta-analysis

C. Kieling, V. Mondelli, H. Fisher, 2021, Psychoneuroendocrinology.

Protocol for a systematic review of the development of depression among adolescents and young adults: psychological, biological, and contextual perspectives around the world

C. Kieling, J. Swartz, V. Mondelli, 2019, Systematic Reviews.

The Identifying Depression Early in Adolescence Risk Stratified Cohort (IDEA-RiSCo): Rationale, Methods, and Baseline Characteristics

C. Kieling, L. Rohde, J. Swartz, 2021, Frontiers in Psychiatry.

Genetic and Real-World Clinical Data , Combined with Empirical Validation , Nominate Jak-Stat Signaling as a Target for Alzheimer ’ s Disease Therapeutic Development

Guy B. Williams, Nicole, Tobias C. Wood, 2019 .

The interaction between kynurenine pathway, suicidal ideation and augmentation therapy with minocycline in patients with treatment-resistant depression

C. Pariante, N. Mariani, V. Mondelli, 2023, Journal of psychopharmacology.

A Modest Increase in 11C-PK11195-Positron Emission Tomography TSPO Binding in Depression Is Not Associated With Serum C-Reactive Protein or Body Mass Index

Karen H. Adams, E. Bullmore, F. Turkheimer, 2021, Biological psychiatry. Cognitive neuroscience and neuroimaging.

In(s) and out(s) of adolescent depression – Trajectories of development and recovery

Z. Zajkowska, 2021, Brain, behavior, & immunity - health.

A systematic review of the association between biological markers and environmental stress risk factors for adolescent depression.

C. Kieling, J. Swartz, V. Mondelli, 2021, Journal of psychiatric research.

Correction: Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study

E. Bullmore, P. Cowen, W. Drevets, 2020, Translational Psychiatry.

CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice

Tobias C. Wood, Karen H. Adams, C. Webber, 2019, Brain : a journal of neurology.

Reward- and threat-related neural function associated with risk and presence of depression in adolescents: a study using a composite risk score in Brazil.

C. Kieling, L. Rohde, J. Swartz, 2021, Journal of child psychology and psychiatry, and allied disciplines.

Pharmacological modulation of TSPO in microglia/macrophages and neurons in a chronic neurodegenerative model of prion disease

Karen H. Adams, E. Bullmore, F. Turkheimer, 2023, Journal of Neuroinflammation.

Sex-specific inflammatory markers of risk and presence of depression in adolescents.

C. Kieling, J. Swartz, V. Mondelli, 2023, Journal of affective disorders.

Higher immune-related gene expression in major depression is independent of CRP levels: results from the BIODEP study

E. Bullmore, P. Cowen, W. Drevets, 2023, Translational psychiatry.

Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?

C. Pariante, P. Zunszain, Z. Zajkowska, 2015, Psychopharmacology.

Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome

M. Hotopf, C. Pariante, N. Harrison, 2019, Psychoneuroendocrinology.

Biomarkers Associated with Treatment Outcome in Young People with Depression: A Systematic Review

Z. Zajkowska, Anna Zierotin, V. Mondelli, 2024, Neuroscience Applied.

Inflammation and immune system pathways as biological signatures of adolescent depression—the IDEA-RiSCo study

Z. Zajkowska, L. Sforzini, V. Zonca, 2024, Translational psychiatry.

Transcriptomic profiles in major depressive disorder: the role of immunometabolic and cell-cycle-related pathways in depression with different levels of inflammation.

L. Pointon, M. Nettis, N. Nikkheslat, 2024, Molecular psychiatry.

Disturbed sex hormones milieu in males and females with major depressive disorder and low-grade inflammation.

L. Pointon, N. Mariani, M. Nettis, 2024, Journal of affective disorders.

A collaborative realist review of remote measurement technologies for depression in young people

Z. Zajkowska, A. Walsh, M. Malys, 2024, Nature human behaviour.